MOH | ||
---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 69 | |
SMR RATING 1..100 | 36 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 84 | |
SEASONALITY SCORE 1..100 | 95 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IHF | MOH | |
---|---|---|
RSI ODDS (%) | N/A | 5 days ago68% |
Stochastic ODDS (%) | 5 days ago84% | 5 days ago64% |
Momentum ODDS (%) | 5 days ago86% | 5 days ago62% |
MACD ODDS (%) | 5 days ago83% | 5 days ago57% |
TrendWeek ODDS (%) | 5 days ago81% | 5 days ago63% |
TrendMonth ODDS (%) | 5 days ago81% | 5 days ago61% |
Advances ODDS (%) | 8 days ago81% | 8 days ago67% |
Declines ODDS (%) | 21 days ago82% | 12 days ago61% |
BollingerBands ODDS (%) | 5 days ago90% | 5 days ago68% |
Aroon ODDS (%) | 5 days ago75% | 5 days ago58% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
AVXC | 57.58 | 0.51 | +0.89% |
Avantis Emerging Markets Ex-Chn Eq ETF | |||
XBI | 85.24 | 0.45 | +0.53% |
SPDR® S&P Biotech ETF | |||
ROMO | 32.10 | 0.04 | +0.13% |
Strategy Shares Nwfnd/RSlv Rbt Mmt ETF | |||
JIII | 50.59 | -0.02 | -0.04% |
Janus Henderson Income ETF | |||
BLE | 10.06 | -0.03 | -0.30% |
BlackRock Municipal Income Trust II |
A.I.dvisor indicates that over the last year, IHF has been closely correlated with ELV. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IHF jumps, then ELV could also see price increases.
A.I.dvisor indicates that over the last year, MOH has been closely correlated with CNC. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if MOH jumps, then CNC could also see price increases.